Patent application number | Description | Published |
20110100611 | THERMOELECTRIC ENERGY STORAGE SYSTEM AND METHOD FOR STORING THERMOELECTRIC ENERGY - A system and method are provided for thermoelectric energy storage. A thermoelectric energy storage system having at least one hot storage unit is provided. In an exemplary embodiment, each hot storage unit includes a hot tank and a cold tank connected via a heat exchanger and containing a thermal storage medium. The thermoelectric energy storage system also includes a working fluid circuit for circulating working fluid through each heat exchanger for heat transfer with the thermal storage medium. Improved roundtrip efficiency is achieved by minimizing the temperature difference between the working fluid and the thermal storage medium in each heat exchanger during heat transfer. Exemplary embodiments realize this improved roundtrip efficiency through modification of thermal storage media parameters. | 05-05-2011 |
20110139407 | THERMOELECTRIC ENERGY STORAGE SYSTEM AND METHOD FOR STORING THERMOELECTRIC ENERGY - A system and method for thermoelectric energy storage are disclosed. A thermoelectric energy storage system can include a heat exchanger which contains a thermal storage medium, and a working fluid circuit for circulating a working fluid through the heat exchanger for heat transfer with the thermal storage medium. The working fluid undergoes transcritical cooling during the charging and transcritical heating during the discharging cycle as it exchanges heat with the thermal storage medium. Improved roundtrip efficiency can be achieved through minimizing the maximum temperature difference (ΔTmax) between the working fluid and the thermal storage medium during operating cycles. | 06-16-2011 |
20130087301 | THERMOELECTRIC ENERGY STORAGE SYSTEM AND METHOD FOR STORING THERMOELECTRIC ENERGY - A thermoelectric energy storage system includes an intercooler for intercooling a working fluid between two compression stages. The intercooling may be carried out by flashing a portion of the working fluid taken from the output of an expander in a flash intercooler and/or by heating a secondary thermal storage with a further heat exchanger. | 04-11-2013 |
20140060051 | THERMOELECTRIC ENERGY STORAGE SYSTEM - A thermoelectric energy storage system and method are provided for storing electrical energy by transferring thermal energy to a thermal storage in a charging cycle, and for generating electricity by retrieving the thermal energy from the thermal storage in a discharging cycle. The thermoelectric energy storage includes a working fluid circuit configured to circulate a working fluid through a heat exchanger, and a thermal storage conduit configured to transfer a thermal storage medium from a thermal storage tank through the heat exchanger. The working fluid includes a zeotropic mixture. The working fluid is in a mixed vapor and liquid phase and has continuously rising or continuously falling temperature during heat transfer due to the working fluid including the zeotropic mixture. | 03-06-2014 |
Patent application number | Description | Published |
20150313873 | Derivatives of Fluorene, Anthracene, Xanthene, Dibenzosuberone and Acridine and Uses Thereof - Chemical agents, such as disulfonamide derivatives of fluorene, anthracene, xanthene, dibenzosuberone and acridine, and similar heterocyclic ring structures, including salts thereof, that act as anti-cancer and anti-tumor agents, especially where such agents modulate the activity of the Wnt/β-catenin signaling pathway, and serve to reduce β-catenin levels present in cells, such as cancer cells, or where the agents modulate levels of gene expression in cellular systems, including cancer cells, are disclosed, along with methods for preparing such agents, as well as pharmaceutical compositions containing such agents as active ingredients and methods of using these as therapeutic agents. | 11-05-2015 |
Patent application number | Description | Published |
20090036429 | Hydroxypiperidine Derivatives and Uses Thereof - Chemical agents, such as derivatives of hydroxypiperidine moieties, and similar heterocyclic ring structures, including salts thereof, that act as anti-cancer and anti-tumor agents, especially where such agents modulate the activity of enzymes and structural polypeptides present in cells, such as cancer cells, or where the agents modulate levels of gene expression in cellular systems, including cancer cells, are disclosed, along with methods for preparing such agents, as well as pharmaceutical compositions containing such agents as active ingredients and methods of using these as therapeutic agents. | 02-05-2009 |
20100137354 | DERIVATIVES OF FLUORENE, ANTHRACENE, XANTHENE, DIBENZOSUBERONE AND ACRIDINE AND USES THEREOF - Chemical agents, such as disulfonamide derivatives of fluorene, anthracene, xanthene, dibenzosuberone and acridine, and similar heterocyclic ring structures, including salts thereof, that act as anti-cancer and anti-tumor agents, especially where such agents modulate the activity of the Wnt/β-catenin signaling pathway, and serve to reduce β-catenin levels present in cells, such as cancer cells, or where the agents modulate levels of gene expression in cellular systems, including cancer cells, are disclosed, along with methods for preparing such agents, as well as pharmaceutical compositions containing such agents as active ingredients and methods of using these as therapeutic agents. | 06-03-2010 |
20100249111 | MULTI-RING COMPOUNDS AND USES THEREOF - Chemical agents, such as derivatives of hydroxy benzene moieties, and similar heterocyclic ring structures, including salts thereof, that act as anti-cancer and anti-tumor agents, especially where such agents modulate the activity of enzymes and structural polypeptides present in cells, such as cancer cells, or where the agents modulate levels of gene expression in cellular systems, including cancer cells, are disclosed, along with methods for preparing such agents, as well as pharmaceutical compositions containing such agents as active ingredients and methods of using these as therapeutic agents. | 09-30-2010 |
20110178066 | Hydroxypiperidine derivatives and uses thereof - Chemical agents, such as derivatives of hydroxypiperidine moieties, and similar heterocyclic ring structures, including salts thereof, that act as anti-cancer and anti-tumor agents, especially where such agents modulate the activity of enzymes and structural polypeptides present in cells, such as cancer cells, or where the agents modulate levels of gene expression in cellular systems, including cancer cells, are disclosed, along with methods for preparing such agents, as well as pharmaceutical compositions containing such agents as active ingredients and methods of using these as therapeutic agents. | 07-21-2011 |
20120129837 | Derivatives of Fluorene, Anthracene, Xanthene, Dibenzosuberone and Acridine and Uses Thereof - Chemical agents, such as disulfonamide derivatives of fluorene, anthracene, xanthene, dibenzosuberone and acridine, and similar heterocyclic ring structures, including salts thereof, that act as anti-cancer and anti-tumor agents, especially where such agents modulate the activity of the Wnt/β-catenin signaling pathway, and serve to reduce β-catenin levels present in cells, such as cancer cells, or where the agents modulate levels of gene expression in cellular systems, including cancer cells, are disclosed, along with methods for preparing such agents, as well as pharmaceutical compositions containing such agents as active ingredients and methods of using these as therapeutic agents. | 05-24-2012 |
Patent application number | Description | Published |
20100137354 | DERIVATIVES OF FLUORENE, ANTHRACENE, XANTHENE, DIBENZOSUBERONE AND ACRIDINE AND USES THEREOF - Chemical agents, such as disulfonamide derivatives of fluorene, anthracene, xanthene, dibenzosuberone and acridine, and similar heterocyclic ring structures, including salts thereof, that act as anti-cancer and anti-tumor agents, especially where such agents modulate the activity of the Wnt/β-catenin signaling pathway, and serve to reduce β-catenin levels present in cells, such as cancer cells, or where the agents modulate levels of gene expression in cellular systems, including cancer cells, are disclosed, along with methods for preparing such agents, as well as pharmaceutical compositions containing such agents as active ingredients and methods of using these as therapeutic agents. | 06-03-2010 |
20120129837 | Derivatives of Fluorene, Anthracene, Xanthene, Dibenzosuberone and Acridine and Uses Thereof - Chemical agents, such as disulfonamide derivatives of fluorene, anthracene, xanthene, dibenzosuberone and acridine, and similar heterocyclic ring structures, including salts thereof, that act as anti-cancer and anti-tumor agents, especially where such agents modulate the activity of the Wnt/β-catenin signaling pathway, and serve to reduce β-catenin levels present in cells, such as cancer cells, or where the agents modulate levels of gene expression in cellular systems, including cancer cells, are disclosed, along with methods for preparing such agents, as well as pharmaceutical compositions containing such agents as active ingredients and methods of using these as therapeutic agents. | 05-24-2012 |
20150313873 | Derivatives of Fluorene, Anthracene, Xanthene, Dibenzosuberone and Acridine and Uses Thereof - Chemical agents, such as disulfonamide derivatives of fluorene, anthracene, xanthene, dibenzosuberone and acridine, and similar heterocyclic ring structures, including salts thereof, that act as anti-cancer and anti-tumor agents, especially where such agents modulate the activity of the Wnt/β-catenin signaling pathway, and serve to reduce β-catenin levels present in cells, such as cancer cells, or where the agents modulate levels of gene expression in cellular systems, including cancer cells, are disclosed, along with methods for preparing such agents, as well as pharmaceutical compositions containing such agents as active ingredients and methods of using these as therapeutic agents. | 11-05-2015 |